Current knowledge on adverse endocrine disruption effects of persistent organic pollutants (POPs) among newborn infants is limited and often controversial. To investigate the associations between prenatal exposure to major POPs and thyroid hormone levels among newborn infants, both cord serum or maternal serum concentrations of polychlorinated biphenyls (PCBs), polybrominated diphenyl ethers (PBDEs), and organochlorine pesticides (OCPs) were compared with five thyroid hormones in cord serum of newborn infants as well as TSH in bloodspot collected at 2 day after birth (n=104). Since cord serum thyroid hormones could be affected by those of mothers, thyroid hormone concentrations of the matching mothers at delivery were adjusted. In cord serum, BDE-47, -99, and Σchlordane (CHD) showed significant positive associations with cord or bloodspot TSH. At the same time, p,p'-dichlorodiphenyldichloroethylene (p,p'-DDE) and hexachlorbenzene (HCB) showed negative associations with total T3 and total T4 in cord serum, respectively. Maternal exposure to β-hexachlorhexane (β-HCH), ΣCHD, ΣDDT, or p,p'-DDE were also associated with neonatal thyroid hormones. Although the sample size is small and the thyroid hormone levels of the subjects were within the reference range, our observation supports thyroid disrupting potential of several POPs among newborn infants, at the levels occurring in the general population. Considering the importance of thyroid hormones during gestation and early life stages, health implication of thyroid hormone effects by low level POPs exposure deserves further follow up investigations.
Citation: Kim S, Park J, Kim H-J, Lee JJ, Choi G, Choi S, et al. (2015) Association between Several Persistent Organic Pollutants and Thyroid Hormone Levels in Cord Blood Serum and Bloodspot of the Newborn Infants of Korea. PLoS ONE10(5): e0125213. https://doi.org/10.1371/journal.pone.0125213
Academic Editor: Aimin Chen, University of Cincinnati, UNITED STATES
Received: August 28, 2014; Accepted: March 23, 2015; Published: May 12, 2015
Copyright: © 2015 Kim et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: This work was supported by a grant (11162MFDS722) from the Ministry of Food and Drug Safety of Korea(http://rnd.mfds.go.kr) in 2011 and the National Research Foundation of Korea (Project 2012R1A2A2A01015236, http://www.nrf.re.kr/nrf_eng_cms). S. M. Kim is supported by BK 21 Plus program of National Research Foundation of Korea (https://bkplus.nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Persistent organic pollutants (POPs) have been detected in various environmental media and biota worldwide, even though many of these compounds including organochlorine pesticides (OCPs), and polychlorinated biphenyls (PCBs), had been banned for use several decades ago. Dichlorodiphenyltrichloroethane (DDT), one of best known OCPs, had been widely used for vector control, and has been frequently detected in humans worldwide [1, 2]. Polybrominated diphenyl ethers (PBDEs) are a group of emerging POPs that have been relatively recently recognized for widespread contamination and adverse health effects [3, 4]. In both wildlife and humans, adverse reproductive, developmental, neurologic, and endocrine health effects have been well-documented for many POPs .
POPs can cross the placenta during pregnancy , occur in breastmilk [7, 8], and therefore can affect the endocrine system of fetuses and breastfed infants. The early life stages are particularly vulnerable to chemical exposures because of incomplete metabolic activities , and rapid somatic growth and development . The exposure to chemicals including POPs among developing fetus has been also suggested to be linked to the adverse health effects of later stages of life [11, 12].
Exposure to POPs has been associated with disruption of thyroid hormones in several human epidemiological studies [13–23]. Thyroid hormones are essential for normal growth and development of the fetus during the most of gestation period . Among pregnant women, even moderate changes of thyroid hormone levels can be associated with adverse outcomes among the mother or her offspring [25–27]. In previous studies, while within reference range, higher maternal thyroid stimulating hormone (TSH) levels were associated with an increased risk of miscarriages, fetal and neonatal distress  and preterm delivery . In addition, high free thyroxin (T4) levels within the normal reference range were associated with reduced preterm delivery rate . Considering the importance of thyroid hormones among the developing fetus and newborn infants, therefore even small changes in thyroid hormones in these vulnerable populations are of potential concern. Associations between prenatal POPs exposure and thyroid hormone levels among newborn infants have been investigated by several groups, but the results are generally inconsistent and often controversial [16–18, 31–33]. Since thyroid hormone levels of cord blood serum are significantly influenced by maternal hormones [34, 35] and show significant fluctuations during and shortly after the delivery , it is quite challenging to identify the true association, if any, between POPs exposure and thyroid hormone levels in cord serum.
Our group has been investigating the POPs exposure among a matched pregnant woman and fetus panel of Korea, i.e., Children’s Health and Environmental Chemicals in Korea Panel (CHECK Panel) and their associations with adverse health outcomes including thyroid hormone levels [7, 37–39]. The CHECK Panel is composed of pregnant women-fetus pairs without any known occupational exposure pathways to major POPs such as OCPs, PCBs, and PBDEs, and was recruited since 2011 from four cities of Korea. Recently, from the pregnant women (n = 105) of this panel we reported negative associations between PBDEs/PCBs exposure and thyroid hormone levels .
In the present study, the associations between prenatal exposure to various POPs, and thyroid hormone status of the newborn infant population of the CHECK Panel were investigated. In order to account for the influence of maternal thyroid inputs, thyroid hormone levels in cord serum were adjusted for maternal thyroid hormone concentrations. For thyroid hormones, e.g., T4, significant maternal-fetal transfer during gestation has been reported . Moreover, the levels of each of free T4, total T4, or total T3 were shown moderate associations between maternal and cord blood serum (Spearman’s rho = 0.13–0.24, p<0.05) in the mother-fetus pairs in the CHECK Panel (S1 Table). TSH levels measured at 2 days after birth were also employed, because of potential significant fluctuations in TSH levels during and shortly after the delivery . The results of this study will help better understand the influences of prenatal POPs exposure on newborn infants, and identify the areas that warrant further investigations in the future.
Study population and sample collection
A total of 148 healthy pregnant women without histories of pre-pregnancy thyroid disease or pregnancy induced thyroid diseases were recruited before delivery from five university hospitals located in four cities of Korea, i.e., Seoul, Anyang, Ansan, and Jeju, reflecting a megacity, a mid-sized residence city, a mid-sized industrial city, and a mid-sized island city, respectively. Their matching fetuses were also recruited after full-term normal delivery. Details about the participating women can be found elsewhere . During delivery, maternal blood and umbilical cord blood were collected, separated for serum on site, and stored in polypropylene cryovials at −70°C until analysis. Among them, POPs and thyroid hormones were analyzed in blood serum of 104 matching pairs (Table 1). In addition, on day 2 post-partum, bloodspot was obtained from each participating newborn infant by heel prick method, except for 5 infants who were sampled at days 5 and 7 post-partum. Institutional Review Boards of School of Public Health, Seoul National University, and all participating university hospitals approved the study, and the informed written consents were obtained from the participating women. All samples and data were processed blind.
Umbilical cord serum samples were processed and measured for 19 PCB congeners, 19 PBDE congeners, and 19 OCPs, consistently with previous study . In addition, levels of five thyroid hormones, i.e., free/total triiodothyronine (T3), free/total T4, and TSH, were obtained. All thyroid hormones were analyzed by electrochemiluminescence immunoassay at Samkwang Medical Laboratories (Seoul, Korea), and the details for thyroid hormone measurements were provided in our previous report . For POPs quantification, 13C-labeled 8 PCBs (EC9605-SS; Wellington Laboratories, Guelph, ON, Canada), 13C-labelled 6 PBDEs (MBDE-MXE; Wellington) and 13C-labeled 19 OCPs (ES-5349-L; Cambridge Isotope Laboratories, Andover, MA, USA) were used as surrogate internal standards. Limit of quantification (LOQ) was calculated as 10 times the signal to noise ratio. The respective LOQs for OCPs, PCBs and PBDEs were from 0.7 to 1.7 ng/g lipid weight (lw), from 0.8 to 8.3 ng/g lw and from 0.2 to 0.8 ng/g lw, respectively. All the POP concentrations were adjusted by the lipid contents of serum. Total lipid (mg/dL) was calculated from the concentrations of total cholesterol and triglyceride by the following equation :
Total cholesterol and triglyceride were analyzed by enzymatic methods in a commercial clinical laboratory (Samkwang Laboratory, Seoul, Korea).
Details of sample preparation and instrumental analysis including quality assurance can be found in S1 Text. TSH levels from bloodspots (n = 96) were analyzed as a part of a national screening program of Korea, by radioimmunoassay. One-on-one interview with participating pregnant women was conducted at the time of enrollment. Demographic characteristics, physiological data, and pregnancy related record were obtained.
Among 57 target POPs, eight compounds of which detection frequencies were ≥ 60% in serum and the sum of the isomers (ΣPCB, ΣPBDE, ΣDDT, Σchlordane (CHD), Σhexachlorhexane (HCH)) were employed for statistical analysis. For chemicals that were detected ≥ 75% of the population, a proxy value, i.e., limit of quantification (LOQ) divided by square root 2, was used to replace the non-detects . For chemicals that were detected in < 75% but ≥ 60%, statistical analysis was conducted only with the detected values, in order to minimize the influence of non-detects.
Both dependent and independent variables were natural log-transformed to minimize the effect of highly right-skewed data, and were analyzed in multivariate analysis. To determine associations between POPs and thyroid hormone measurements in cord serum, multiple linear regression models were built with each chemical and each thyroid hormone. In addition, covariates that have been reportedly associated with the thyroid hormones elsewhere [42, 43] including age, maternal weight-gain during pregnancy, gestational age (days), mode of delivery, parity, pre-pregnancy BMI, and smoking status during pregnancy (yes/no) were included in the models. The former three covariates were continuous variables while the latter four were categorical. Because cord serum thyroid levels can be affected by the maternal input of thyroid hormones [34, 35], and also we found that the levels of free/total T4 and total T3 were positively correlated with its counterpart between maternal and cord serum in the CHECK population, therefore, respective thyroid hormone concentrations of the matching mother were also added into the model. For example, we included respective maternal thyroid hormone (e.g., free T4) as a covariate in the cord thyroid hormone (e.g., free T4) regression model. Unlike cord serum thyroid hormones, bloodspot TSH that was measured at 2 days of age was considered to be independent of maternal TSH input. As infant sex was determined to be significantly associated with bloodspot TSH, infant sex was added as covariate for analysis of bloodspot TSH, and smoking status was removed. For multivariate analysis, significance of linear model and normality of the residuals were checked. P < 0.05 was set as significant results, but considering small sample size, p < 0.10 was also shown as marginal significance. Percent changes in thyroid hormone levels expected for an interquartile range (IQR) increase of a given chemical concentration were back-calculated from the regression coefficients for each target chemical .
Sensitivity analysis was conducted if the following two criteria were met: 1) when two or more independent variables (i.e., POPs) were significantly associated with the same dependent variable (i.e., thyroid hormone levels); and 2) when the same independent variables were significantly correlated with each other based on the Spearman correlation test (S2 and S3 Tables). In the sensitivity analysis, the identified independent variables were then included in multivariate models to estimate βs and 95% confidence intervals (CIs) for thyroid hormone levels. SAS 9.3 (SAS Institute Inc., Cary, NC, USA) was used for statistical analyses.
Characteristics of study population
General characteristics of the participating women and their newborn infants, along with the levels of thyroid hormones are summarized in Table 1. The ages of the participating pregnant women are generally in their early 30s, and about a half of the women were primiparae. Approximately two thirds of the participating women gave birth to babies by spontaneous vaginal delivery. Before pregnancy, most women were within normal weight range, with a mean pre-pregnancy BMI of 21.8 kg/m2. All TSH measurements in bloodspot papers were below 20 μlU/mL, showing no infant with congenital hypothyroidism [36, 45].
POPs concentrations in cord blood serum
Several target compounds were detected in ≥ 60% of samples (Table 2). Among the target POPs, only p,p’-dichlorodiphenyldichloroethylene (p,p’-DDE) was detected in > 90% of cord serum samples. Detection levels of POPs in cord serum were generally similar to those of maternal serum, but detection frequencies were generally lower. The concentration of ΣPCB and ΣPBDE were higher in the cord serum than in the maternal serum. In cord serum, ΣPCB and ΣPBDE were detected at a median of 34.7 ng/g lw (interquartile range (IQR) of 18.4–55.5) and 8.8 ng/g lw (4.9–14.3), respectively, while those were detected at 23.5 (15.7–33.5) and 2.23 ng/g lw (1.5–4.6) in maternal serum. Most of the POPs were positively correlated with each other in cord or maternal serum. In cord serum, PCB-153 was correlated with many other chemicals including ΣPBDE, BDE-99, ΣHCH, trans-Nonachlordane (tNCHD), ΣDDT, p,p’-DDE (S2 Table). In maternal serum, p,p’-DDE was correlated with other chemicals like ΣPBDE, BDE-47, ΣHCH, β-HCH, ΣCHD, tNCHD, and ΣDDT (S3 Table).
Association between cord serum POPs and thyroid hormone concentrations of newborn infants
Out of eight target POPs, five chemicals showed significant associations with thyroid hormone levels of newborn infants after adjustment of the covariates (Table 3). Significant negative association was detected between cord serum hexachlorobenzene (HCB) and total T4, with 5.8% (95% CI, -10.9 to -0.4) decline in total T4 by an IQR increase in HCB levels (increase from 2.8 to 2.3 ng/g lw, see Table 2 for this and other IQRs). Positive associations were detected between cord BDE-47 and bloodspot TSH, and between cord BDE-99 and cord TSH. An IQR increase of BDE-47 and -99 was associated with a 30.4% (95% CI, 2.6 to 65.7) increase of bloodspot TSH, and a 21.2% (95% CI, 0.1 to 46.8) increase of cord TSH, respectively. In addition, p,p’-DDE showed significant positive association with bloodspot TSH, and marginally significant negative association with total T3. A 16.5% (95% CI, 1.9 to 33.2) increase of bloodspot TSH was associated with an IQR increase of p,p’-DDE in cord serum. Cord ΣCHD and cord TSH levels were positively related as well. In contrast, ΣPCB and β-HCH concentrations showed negative trend with bloodspot TSH, but the association was not significant. The concentrations of PCB-52, -153, and tNCHD were not associated with thyroid hormones in cord blood serum samples of the present study.
Following the sensitivity analysis, most marginally significant associations between POPs and thyroid hormones disappeared. However, positive associations between BDE-47 and bloodspot TSH, and p,p’-DDE and bloodspot TSH were remained significant even after the sensitivity analysis (Table 4).
Association between maternal serum POPs and thyroid hormone concentrations of newborn infants
Among target chemicals, maternal β-HCH, ΣCHD, ΣDDT, and p,p’-DDE were significantly associated with thyroid hormones of newborn infants. In addition, BDE-47, tNCHD, and HCB were marginally associated (Table 5). β-HCH showed negative associations with both free and total T3, and an IQR increase of β-HCH was related with 4.7% (95% CI, -8.4 to -0.7) decrease of free T3, and 4.1% (95% CI, -8.0 to -0.1) decrease of total T3. ΣCHD were negatively related with both free and total T4: 2.3% (95% CI, -4.4 to -0.1) decline of free T4 was associated with an IQR increase of ΣCHD in maternal serum. Both ΣDDT, and p,p’-DDE showed significant positive associations with bloodspot TSH (25% and 19% of increase following IQR increase of ΣDDT, and p,p’-DDE, respectively).
In sensitivity analysis, p,p’-DDE was found to be a predominant determinant of bloodspot TSH (Table 4). Multivariate model analysis with bloodspot TSH and its three significant variables, i.e., BDE-47, ΣDDT and p,p’-DDE, showed even stronger association of p,p’-DDE (β = 0.45; 95% CI, 0.14, 0.76; p<0.01). However, both maternal β-HCH and ΣCHD became insignificant after adjustment of maternal p,p’-DDE in the free T3 and free/total T4 models.
Influence of maternal thyroid hormones on the effect of POPs to neonatal thyroid hormones
Relatively few studies have been conducted on the association between POPs exposure and thyroid hormones among newborn infants (Table 6), and these observations generally showed inconsistent results. For example, while several studies reported the increase of TSH and decreases of T3 or T4, which are similar to the results of experimental studies on PBDEs [16, 21, 32, 46], PCBs [17, 22, 32, 47], or OCPs [20, 48, 49], the associations of the opposite directions or no association were also reported [18, 22, 33, 50–52], even within the same study . Seemingly inconsistent associations between prenatal POPs exposure and the thyroid hormones in cord serum may be explained by several reasons. First, thyroid hormone levels in cord serum could be influenced by maternal transfer of thyroid hormones. Maternal thyroid hormones can be transferred to the fetus by perfusion system of placenta and blood exchange via cord. Fetuses depend entirely on the maternal supply of T4 during the first trimester and continue to depend on the maternal supply to varying degrees throughout the pregnancy . At birth, around 30–60% of thyroid hormones in cord blood are of maternal origin [34, 35]. Therefore, thyroid hormones measured in cord serum could be influenced by the physiological or environmental factors that could affect maternal thyroid hormone levels. Second, several factors related to maternal, fetal, and delivery conditions may influence the thyroid status of the fetus. For example, delivery associated factors, such as mode of delivery, time of labor, emergency cesarean section, and induced labor, are reported to be related with intrapartum stress of mother and fetus , leading to rapid changes of thyroid hormone levels until shortly after birth . Because controlling the labor- or delivery-related factors is almost impossible in human study, those variables that may influence the fetal thyroid hormones should be identified and adjusted in the study design.
To our knowledge, no study has adjusted maternal hormone effects for examination of the relation between POPs and thyroid hormones in cord serum. The reason for inconsistent directions of association between POPs exposure and thyroid hormone levels in cord blood serum among studies may be partly due to such fact. In the present study, in order to minimize the influences of the factors that would confound the association between cord serum thyroid hormone levels and prenatal POPs exposure, first, we included maternal thyroid hormone level as covariate in the multivariate analysis model. Second, TSH levels measured in bloodspot collected at 2 day post-partum were also employed for the association with prenatal POPs exposure. Since TSH is maintained consistent after 24 hrs of delivery, bloodspot TSH levels of the newborn infants at 2 day post-partum are considered relatively independent from the influence of the maternal thyroid hormone inputs . In this context, Hardy et al. reported that bloodspot TSH showed better sensitivity than cord serum TSH, and was better than cord serum T4 for screening congenital hypothyroidism .
Unlike our expectation, however, adding maternal thyroid hormone levels as covariates did not generally influence the association between POPs and cord serum thyroid hormone levels, while the p values of the association became lesser for some POPs, e.g., ∑PCB in cord and tNCHD in maternal serum (S4 Table). Other important factors, rather than POPs exposure and maternal thyroid hormones, may exist, and may more accurately explain the thyroid hormone levels in cord serum. The utility of the adjustment of maternal thyroid hormones warrants further evaluation in other pregnant women-fetus pair populations.
Association between POPs exposure and thyroid hormones
While statistical significance was not always detected, many POPs in cord serum generally showed negative associations with T3 or T4 levels, and at the same time showed positive associations with TSH levels in cord serum. Similar trends were also observed between POPs in maternal serum and thyroid hormones in cord serum. These observations are comparable to our recent observations in pregnant women  and several experimental studies [55–60], and suggest that at the current levels of exposure, several OCPs and PBDEs may be associated with subclinical hypothyroidism among pregnant women and newborn infants.
Our findings that prenatal exposure to OCPs (p,p’-DDE, HCB, β-HCH, and ∑CHD) appeared to be associated with T3, T4 of cord serum, and TSH of bloodspot were consistent with experimental study results [60–62]. In the 30-days exposure, reduced free and total T4 levels were observed following HCB treatment in rats [61, 62]. In experiment using sparrows, p,p’-DDT exposure led to decreased thyroid hormone levels, and inhibition of TSH receptor was suggested as one of the mechanisms for thyroid hormone disruption of DDTs [60, 63]. CHDs can interfere the cellular uptake of thyroid hormones, which may result in reduction of T3 or T4 levels .
The effect of OCPs appeared to be more evident among newborn infants compared to their matching mothers . Early developmental stages are considered to be more sensitive to exposure to OCPs . Potential epigenetic transgenerational action of several OCPs on endocrine system [66, 67] could also in part explain the observed sensitivity of newborn infants toward OCPs.
The significant positive associations between BDE-47 and bloodspot TSH, and between BDE-99 and cord serum TSH, which remained even after the adjustment of other related chemicals (Table 3 and S4 Table) suggest the effects of PBDEs on thyroid hormone homeostasis among newborn infants. PBDEs, especially BDE-47, were suggested to disrupt thyroid hormones through increase of hepatic enzyme related with glucuronidation, or decrease of transport protein such as transthyretin [68, 69]. Although human study is still sparse and the results are not consistent, our observation among the newborn infants is comparable to those of experimental studies [70, 71], and warrants further confirmation in the epidemiological studies.
The observation of no significant association between prenatal PCBs exposure and thyroid hormone levels among newborn infant population in the present study is different from the result in maternal serum where significant relationships between PCB exposure and total T3 or T4 were observed . Total PCB in cord serum shows only weak effects (p < 0.10) on cord total T3 and bloodspot TSH levels (Table 3). However, these weak influences of total PCB disappeared by adding p,p’-DDE and BDE-47 of cord serum in the model (Table 4), suggesting that the effects of total PCB on thyroid hormones was probably confounded by PBDEs and OCPs. This null-association is not consistent with experimental results employing rats [58, 72, 73]. However, several epidemiological studies regarding thyroid hormone and PCB in newborns also failed to detect such significant observations [16, 31, 33, 49–51]. For example, no effect on thyroid hormones was observed with prenatal PCB exposure [33, 51], even though significant associations with other POPs were observed in the same population [16, 49, 50].
Why do PCBs influence thyroid hormone levels differently between pregnant women and newborn infants? While direct answer to this question is not ready, a couple of reasons can be considered in the future studies. First, potential differences in thyroid-related metabolic pathways between pregnant women and newborn infants should be considered . In the same condition of marginal iodine deficiency, newborns were better protected from hypothyroxinemia compared to mothers, suggesting their different physiological responses . Second, compared to other chemicals, PCBs are regarded to possess more complex mechanisms of action of thyroid-disruption, e.g., on the function of the TSH receptor, binding transport proteins, hormone receptor and gene expression, and excretion/clearance of thyroid hormones . Such complex dynamics may have obscures true associations.
Summary and implications
In the present study, the associations between thyroid hormone levels and prenatal POPs exposure were observed among the matching pregnant women-newborn infant pairs. Several OCPs, such as β-HCH, p,p’-DDE and HCB, and PBDEs, such as BDE-47 and BDE-99, were identified to be significantly associated with decreased T3 or T4, or increased TSH concentrations (Tables 3–5). However, the present study has a number of limitations that should be considered in the interpretation of the results. First, small sample size may lead to statistical significance by chance, and increased Type I error in regression models due to potential interactions between independent variables. Second, immunoassay measurements of free hormones can be affected by serum albumin, fatty acids, and other binding proteins that are reported to increase during pregnancy [77, 78]. This should be noted as a limitation in interpretation of the measurement data for free thyroid hormones. Third, thyroid hormones can fluctuate until shortly after the delivery, therefore the time of blood sample collection would influence the level of the hormones. While all the cord serum samples were collected immediately after the delivery, fluctuations in cord serum thyroid hormone levels cannot be ignored, and should be noted as another limitation.
However, our study is unique in that we have measured three groups of POPs (n = 57) and all five thyroid hormones in both maternal and fetal serum samples at the same time. In addition, sensitivity analysis was performed to confirm the influence of the predictors of thyroid hormone levels, i.e., POPs at the current levels of exposure. While the validation of our result in larger populations would be needed, the results of the present study provide another line of evidence that the current OCPs and PBDEs exposure among humans at sensitive life stages could influence the levels of thyroid hormones. The observed association between POPs exposure and bloodspot TSH of newborn infants also supports the same influence of the POPs toward thyroid hormone disruption among newborn infants. Even though thyroid hormone levels are within the reference range, small changes (< 25%) of maternal T4 or TSH during the early fetal period have been associated with adverse health outcomes . Thus, considering the importance of thyroid hormones in rapidly developing bodies, public health implications of thyroid hormone disturbance among newborn infants should receive further investigations. Our observation also emphasizes the importance of further studies on implications at later life stages following the hormonal alteration occurring in the developing infants.
S1 Table. Relationship between thyroid hormone concentrations in cord and maternal samples of the CHECK population.
S2 Table. Spearman correlation table for detected POPs concentrations in cord serum.
S3 Table. Spearman correlation table for detected POPs concentrations in maternal serum.
S4 Table. Results of multivariate analysis with or without maternal thyroid hormone as covariates in the model.
We would like to express our gratitude to all participating mothers of the Children’s Health and Environmental Chemicals in Korea (CHECK) Panel study.
Conceived and designed the experiments: SMK JIP KHC. Performed the experiments: HJK JJL GYC SRC SJK SYK HBM SKK. Analyzed the data: SMK JIP. Contributed reagents/materials/analysis tools: HBM SKK. Wrote the paper: SMK KHC.
- 1. Fujii Y, Haraguchi K, Harada KH, Hitomi T, Inoue K, Itoh Y, et al. (2011) Detection of dicofol and related pesticides in human breast milk from China, Korea and Japan. Chemosphere 82: 25–31. pmid:21051069
- 2. Smith D (1999) Worldwide trends in DDT levels in human breast milk. Int J Epidemiol 28: 179–188. pmid:10342677
- 3. Eriksson P, Jakobsson E, Fredriksson A (2001) Brominated flame retardants: a novel class of developmental neurotoxicants in our environment? Environ Health Perspect 109: 903–908. pmid:11673118
- 4. Siddiqi MA, Laessig RH, Reed KD (2003) Polybrominated diphenyl ethers (PBDEs): new pollutants-old diseases. Clin Med Res 1: 281–290. pmid:15931321
- 5. US EPA (2009) Persistent organic pollutants: A global issue, a global response. United States Environmental Protection Agency. Available: http://www2.epa.gov/international-cooperation/persistent-organic-pollutants-global-issue-global-response. Accessed 22 March 2015.
- 6. Vizcaino E, Grimalt JO, Fernandez-Somoano A, Tardon A (2014) Transport of persistent organic pollutants across the human placenta. Environ Int 65: 107–115. pmid:24486968
- 7. Lee S, Kim S, Lee HK, Lee IS, Park J, Kim HJ, et al. (2013) Contamination of polychlorinated biphenyls and organochlorine pesticides in breast milk in Korea: time-course variation, influencing factors, and exposure assessment. Chemosphere 93: 1578–1585. pmid:24112654
- 8. Gomara B, Herrero L, Ramos JJ, Mateo JR, Fernandez MA, García JF, et al. (2007) Distribution of polybrominated diphenyl ethers in human umbilical cord serum, paternal serum, maternal serum, placentas, and breast milk from Madrid population, Spain. Environ Sci Technol 41: 6961–6968. pmid:17993135
- 9. Dencker L, Eriksson P (1998) Susceptibility in utero and upon neonatal exposure. Food Addit Contam 15: 37–43. pmid:9602910
- 10. Makri A, Goveia M, Balbus J, Parkin R (2004) Children's susceptibility to chemicals: a review by developmental stage. J Toxicol Environ Health B Crit Rev 7: 417–435. pmid:15586877
- 11. Eriksson P, Talts U (2000) Neonatal exposure to neurotoxic pesticides increases adult susceptibility: a review of current findings. Neurotoxicology 21: 37–47. pmid:10794383
- 12. Gascon M, Vrijheid M, Martinez D, Forns J, Grimalt JO, Torrent M, et al. (2011) Effects of pre and postnatal exposure to low levels of polybromodiphenyl ethers on neurodevelopment and thyroid hormone levels at 4 years of age. Environ Int 37: 605–611. pmid:21237513
- 13. Alvarez-Pedrerol M, Guxens M, Ibarluzea J, Rebagliato M, Rodriguez A, Espada M, et al. (2009) Organochlorine compounds, iodine intake, and thyroid hormone levels during pregnancy. Environ Sci Technol 43: 7909–7915. pmid:19921913
- 14. Meeker JD, Altshul L, Hauser R (2007) Serum PCBs, p,p'-DDE and HCB predict thyroid hormone levels in men. Environ Res 104: 296–304. pmid:17189629
- 15. Stapleton HM, Eagle S, Anthopolos R, Wolkin A, Miranda ML (2011) Associations between polybrominated diphenyl ether (PBDE) flame retardants, phenolic metabolites, and thyroid hormones during pregnancy. Environ Health Perspect 119: 1454–1459. pmid:21715241
- 16. Abdelouahab N, Langlois MF, Lavoie L, Corbin F, Pasquier JC, Takser L (2013) Maternal and cord-blood thyroid hormone levels and exposure to polybrominated diphenyl ethers and polychlorinated biphenyls during early pregnancy. Am J Epidemiol 178: 701–713. pmid:23924579
- 17. Chevrier J, Eskenazi B, Bradman A, Fenster L, Barr DB (2007) Associations between prenatal exposure to polychlorinated biphenyls and neonatal thyroid-stimulating hormone levels in a Mexican-American population, Salinas Valley, California. Environ Health Perspect 115: 1490–1496. pmid:17938741
- 18. Chevrier J, Harley KG, Bradman A, Sjodin A, Eskenazi B (2011) Prenatal exposure to polybrominated diphenyl ether flame retardants and neonatal thyroid-stimulating hormone levels in the CHAMACOS study. Am J Epidemiol 174: 1166–1174. pmid:21984658
- 19. Chevrier J, Eskenazi B, Holland N, Bradman A, Barr DB (2008) Effects of exposure to polychlorinated biphenyls and organochlorine pesticides on thyroid function during pregnancy. Am J Epidemiol 168: 298–310. pmid:18550560
- 20. Asawasinsopon R, Prapamontol T, Prakobvitayakit O, Vaneesorn Y, Mangklabruks A, Hock B. (2006) The association between organochlorine and thyroid hormone levels in cord serum: a study from northern Thailand. Environ Int 32: 554–559. pmid:16492389
- 21. Lin SM, Chen FA, Huang YF, Hsing LL, Chen LL, Wu LS, et al. (2011) Negative associations between PBDE levels and thyroid hormones in cord blood. Int J Hyg Environ Health 214: 115–120. pmid:21106438
- 22. Zhang J, Jiang Y, Zhou J, Wu B, Liang Y, Peng Z, et al. (2010) Elevated body burdens of PBDEs, dioxins, and PCBs on thyroid hormone homeostasis at an electronic waste recycling site in China. Environ Sci Technol 44: 3956–3962. pmid:20408536
- 23. Goldner WS, Sandler DP, Yu F, Hoppin JA, Kamel F, Levan TD (2010) Pesticide use and thyroid disease among women in the Agricultural Health Study. Am J Epidemiol 171: 455–464. pmid:20061368
- 24. Forhead AJ, Fowden AL (2014) Thyroid hormones in fetal growth and prepartum maturation. J Endocrinol 221: R87–R103. pmid:24648121
- 25. Berbel P, Mestre JL, Santamaria A, Palazon I, Franco A, Graells M, et al. (2009) Delayed neurobehavioral development in children born to pregnant women with mild hypothyroxinemia during the first month of gestation: the importance of early iodine supplementation. Thyroid 19: 511–519. pmid:19348584
- 26. Idris I, Srinivasan R, Simm A, Page RC (2005) Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome. Clin Endocrinol (Oxf) 63: 560–565. pmid:16268809
- 27. Sahu MT, Das V, Mittal S, Agarwal A, Sahu M (2010) Overt and subclinical thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome. Arch Gynecol Obstet 281: 215–220. pmid:19437026
- 28. Benhadi N, Wiersinga WM, Reitsma JB, Vrijkotte TG, Bonsel GJ (2009) Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur J Endocrinol 160: 985–991. pmid:19273570
- 29. Stagnaro-Green A, Chen XH, Bogden JD, Davies TF, Scholl TO (2005) The thyroid and pregnancy: A novel risk factor for very preterm delivery. Thyroid 15: 351–357. pmid:15876159
- 30. Torremante P, Flock F, Kirschner W (2011) Free thyroxine level in the high normal reference range prescribed for nonpregnant women may reduce the preterm delivery rate in multiparous. J Thyroid Res 2011: 905734. pmid:22203918
- 31. Eggesbo M, Thomsen C, Jorgensen JV, Becher G, Odland JO, Longnecker MP (2011) Associations between brominated flame retardants in human milk and thyroid-stimulating hormone (TSH) in neonates. Environ Res 111: 737–743. pmid:21601188
- 32. Herbstman JB, Sjodin A, Apelberg BJ, Witter FR, Halden RU, Patterson DG, et al. (2008) Birth delivery mode modifies the associations between prenatal polychlorinated biphenyl (PCB) and polybrominated diphenyl ether (PBDE) and neonatal thyroid hormone levels. Environ Health Perspect 116: 1376–1382. pmid:18941581
- 33. Longnecker MP, Gladen BC, Patterson DG Jr., Rogan WJ (2000) Polychlorinated biphenyl (PCB) exposure in relation to thyroid hormone levels in neonates. Epidemiology 11: 249–254. pmid:10784239
- 34. Fisher DA (1997) Fetal thyroid function: diagnosis and management of fetal thyroid disorders. Clin Obstet Gynecol 40: 16–31. pmid:9103947
- 35. Thorpe-Beeston JG, Nicolaides KH, Snijders RJ, Butler J, McGregor AM (1991) Fetal thyroid-stimulating hormone response to maternal administration of thyrotropin-releasing hormone. Am J Obstet Gynecol 164: 1244–1245. pmid:1709782
- 36. Kim SS, Lee JH, Lee DH, Choi TY (2005) Change of TSH, T4, and free T4 concentrations during the 48 hours of postnatal period. Ann Pediatr Endocrinol Metab 10: 147–153.
- 37. Choi G, Kim S, Kim S, Kim S, Choi Y, Kim HJ, et al. (2014) Occurrences of major polybrominated diphenyl ethers (PBDEs) in maternal and fetal cord blood sera in Korea. Sci Total Environ 491–492: 219–226.
- 38. Kim S, Park J, Kim HJ, Lee JJ, Choi G, Choi S, et al. (2013) Association between several persistent organic pollutants and thyroid hormone levels in serum among the pregnant women of Korea. Environ Int 59: 442–448. pmid:23928038
- 39. Lee S, Kim S, Kim E, Lee IS, Choi G, Park JI, et al. (2013) Polybrominated diphenyl ethers (PBDEs) in breast milk of Korea in 2011: current contamination, time course variation, influencing factors and health risks. Environ Res 126: 76–83. pmid:24012248
- 40. Bernert JT, Turner WE, Patterson DG Jr., Needham LL (2007) Calculation of serum "total lipid" concentrations for the adjustment of persistent organohalogen toxicant measurements in human samples. Chemosphere 68: 824–831. pmid:17408721
- 41. Hornung RW, Reed LD (1990) Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg 5: 46–51.
- 42. Franklin RC, Carpenter LM, O'Grady CM (1985) Neonatal thyroid function: influence of perinatal factors. Arch Dis Child 60: 141–144. pmid:3977386
- 43. Herbstman J, Apelberg BJ, Witter FR, Panny S, Goldman LR (2008) Maternal, infant, and delivery factors associated with neonatal thyroid hormone status. Thyroid 18: 67–76. pmid:18302520
- 44. UCLA: Statistical Consulting Group. How do I interpret a regression model when some variables are log transformed? Available: http://www.ats.ucla.edu/stat/mult_pkg/faq/general/log_transformed_regression.htm. Accessed 22 March 2015.
- 45. Kapelari K, Kirchlechner C, Hogler W, Schweitzer K, Virgolini I, Moncayo R (2008) Pediatric reference intervals for thyroid hormone levels from birth to adulthood: a retrospective study. BMC Endocr Disord 8: 15. pmid:19036169
- 46. Kim UJ, Lee IS, Kim HS, Oh JE (2011) Monitoring of PBDEs concentration in umbilical cord blood and breast milk from Korean population and estimating the effects of various parameters on accumulation in humans. Chemosphere 85: 487–493. pmid:21890170
- 47. Hisada A, Shimodaira K, Okai T, Watanabe K, Takemori H, Takasuga T, et al. (2014) Associations between levels of hydroxylated PCBs and PCBs in serum of pregnant women and blood thyroid hormone levels and body size of neonates. Int J Hyg Environ Health 217: 546–553. pmid:24269188
- 48. Maervoet J, Vermeir G, Covaci A, Van Larebeke N, Koppen G, Schoeters G, et al. (2007) Association of thyroid hormone concentrations with levels of organochlorine compounds in cord blood of neonates. Environ Health Perspect 115: 1780–1786. pmid:18087600
- 49. Ribas-Fito N, Sala M, Cardo E, Mazon C, De Muga ME, Verdú A, et al. (2003) Organochlorine compounds and concentrations of thyroid stimulating hormone in newborns. Occup Environ Med 60: 301–303. pmid:12660379
- 50. Dallaire R, Dewailly E, Ayotte P, Muckle G, Laliberte C, Bruneau S (2008) Effects of prenatal exposure to organochlorines on thyroid hormone status in newborns from two remote coastal regions in Quebec, Canada. Environ Res 108: 387–392. pmid:18814871
- 51. Takser L, Mergler D, Baldwin M, de Grosbois S, Smargiassi A, Lafond J (2005) Thyroid hormones in pregnancy in relation to environmental exposure to organochlorine compounds and mercury. Environ Health Perspect 113: 1039–1045. pmid:16079076
- 52. Kim TH, Lee YJ, Lee E, Kim MS, Kwack SJ, Kim KB, et al. (2009) Effects of gestational exposure to decabromodiphenyl ether on reproductive parameters, thyroid hormone levels, and neuronal development in Sprague-Dawley rats offspring. J Toxicol Environ Health A 72: 1296–1303. pmid:20077200
- 53. Contempre B, Jauniaux E, Calvo R, Jurkovic D, Campbell S, de Escobar GM (1993) Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy. J Clin Endocrinol Metab 77: 1719–1722. pmid:8263162
- 54. Hardy JD, Zayed R, Doss I, Dhatt GS (2008) Cord blood thyroxine and thyroid stimulating hormone screening for congenital hypothyroidism: how useful are they? J Pediatr Endocrinol Metab 21: 245–249. pmid:18540251
- 55. Darras VM (2008) Endocrine disrupting polyhalogenated organic pollutants interfere with thyroid hormone signalling in the developing brain. Cerebellum 7: 26–37. pmid:18418666
- 56. Hallgren S, Darnerud PO (2002) Polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs) and chlorinated paraffins (CPs) in rats-testing interactions and mechanisms for thyroid hormone effects. Toxicology 177: 227–243. pmid:12135626
- 57. Zhou T, Ross DG, DeVito MJ, Crofton KM (2001) Effects of short-term in vivo exposure to polybrominated diphenyl ethers on thyroid hormones and hepatic enzyme activities in weanling rats. Toxicol Sci 61: 76–82. pmid:11294977
- 58. Gauger KJ, Kato Y, Haraguchi K, Lehmler HJ, Robertson LW, Bansal R, et al. (2004) Polychlorinated biphenyls (PCBs) exert thyroid hormone-like effects in the fetal rat brain but do not bind to thyroid hormone receptors. Environ Health Perspect 112: 516–523. pmid:15064154
- 59. Martin L, Klaassen CD (2010) Differential effects of polychlorinated biphenyl congeners on serum thyroid hormone levels in rats. Toxicol Sci 117: 36–44. pmid:20573785
- 60. Scollon EJ, Carr JA, Cobb GP (2004) The effect of flight, fasting and p,p'-DDT on thyroid hormones and corticosterone in Gambel's white-crowned sparrow, Zonotrichia leucophrys gambelli. Comp Biochem Physiol C Toxicol Pharmacol 137: 179–189. pmid:15050929
- 61. Foster WG, Pentick JA, McMahon A, Lecavalier PR (1993) Body distribution and endocrine toxicity of hexachlorobenzene (HCB) in the female rat. J Appl Toxicol 13: 79–83. pmid:8486915
- 62. Alvarez L, Hernandez S, Martinez-de-Mena R, Kolliker-Frers R, Obregon MJ, Kleiman de Pisarev DL (2005) The role of type I and type II 5' deiodinases on hexachlorobenzene-induced alteration of the hormonal thyroid status. Toxicology 207: 349–362. pmid:15664263
- 63. Santini F, Vitti P, Ceccarini G, Mammoli C, Rosellini V, Pelosini C, et al. (2003) In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity. J Endocrinol Invest 26: 950–955. pmid:14759065
- 64. Shimada N, Yamauchi K (2004) Characteristics of 3,5,3'-triiodothyronine (T3)-uptake system of tadpole red blood cells: effect of endocrine-disrupting chemicals on cellular T3 response. J Endocrinol 183: 627–637. pmid:15590988
- 65. Vesselinovitch SD, Rao KV, Mihailovich N (1979) Neoplastic response of mouse tissues during perinatal age periods and its significance in chemical carcinogenesis. Natl Cancer I Monogr 51: 239–250. pmid:384263
- 66. Schug TT, Janesick A, Blumberg B, Heindel JJ (2011) Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol 127: 204–215. pmid:21899826
- 67. Skinner MK, Manikkam M, Tracey R, Guerrero-Bosagna C, Haque M, Nilsson EE (2013) Ancestral dichlorodiphenyltrichloroethane (DDT) exposure promotes epigenetic transgenerational inheritance of obesity. BMC medicine 11: 228. pmid:24228800
- 68. Hallgren S, Sinjari T, Hakansson H, Darnerud PO (2001) Effects of polybrominated diphenyl ethers (PBDEs) and polychlorinated biphenyls (PCBs) on thyroid hormone and vitamin A levels in rats and mice. Arch Toxicol 75: 200–208. pmid:11482517
- 69. Richardson VM, Staskal DF, Ross DG, Diliberto JJ, DeVito MJ, Birnbaum LS (2008) Possible mechanisms of thyroid hormone disruption in mice by BDE 47, a major polybrominated diphenyl ether congener. Toxicol Appl Pharmacol 226: 244–250. pmid:17964624
- 70. Abdelouahab N, Suvorov A, Pasquier JC, Langlois MF, Praud JP, Takser L (2009) Thyroid disruption by low-dose BDE-47 in prenatally exposed lambs. Neonatology 96: 120–124. pmid:19321978
- 71. Kodavanti PR, Coburn CG, Moser VC, MacPhail RC, Fenton SE, Stoker TE, et al. (2010) Developmental exposure to a commercial PBDE mixture, DE-71: neurobehavioral, hormonal, and reproductive effects. Toxicol Sci 116: 297–312. pmid:20375078
- 72. Donahue DA, Dougherty EJ, Meserve LA (2004) Influence of a combination of two tetrachlorobiphenyl congeners (PCB 47; PCB 77) on thyroid status, choline acetyltransferase (ChAT) activity, and short- and long-term memory in 30-day-old Sprague-Dawley rats. Toxicology 203: 99–107. pmid:15363586
- 73. Zoeller RT, Dowling AL, Vas AA (2000) Developmental exposure to polychlorinated biphenyls exerts thyroid hormone-like effects on the expression of RC3/neurogranin and myelin basic protein messenger ribonucleic acids in the developing rat brain. Endocrinology 141: 181–189. pmid:10614638
- 74. Glinoer D (1997) The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 18: 404–433. pmid:9183570
- 75. Glinoer D, Delange F, Laboureur I, de Nayer P, Lejeune B, Kinthaert J, et al. (1992) Maternal and neonatal thyroid function at birth in an area of marginally low iodine intake. J Clin Endocrinol Metab 75: 800–805. pmid:1517370
- 76. Boas M, Feldt-Rasmussen U, Skakkebaek NE, Main KM (2006) Environmental chemicals and thyroid function. Eur J Endocrinol 154: 599–611. pmid:16645005
- 77. Spencer CA (2013) Assay of thyroid hormones and related substances. South Dartmouth, MA: Thyroid disease manager.
- 78. Bourcigaux N, Lepoutre-Lussey C, Guechot J, Donadille B, Faugeron I, Ouzounian S, et al. (2010) Thyroid function at the third trimester of pregnancy in a Northern French population. Ann Endocrinol (Paris) 71: 519–524. pmid:20887974
- 79. WHO/UNEP (2012) State of the science of endocrine disrupting chemicals. An assessment of the state of the science of endocrine disruptors prepared by a group of experts for the UNEP and WHO. Edited by Bergman A, Heindel JJ, Jobling S, Kidd KA, Zoeller TR. United Nations Environment Programme, Nairobi, Kenya, and World Health Organization, Geneva, Switzerland.</References>